ALS Society of Canada (ALS Canada)

ALS Canada is a national nonprofit organization dedicated to improving the lives of people living with amyotrophic lateral sclerosis and advancing the search for effective treatments and a future without ALS. Guided by a commitment to compassion, advocacy, and scientific progress, the organization works to ensure that individuals and families affected by ALS receive meaningful support while accelerating research that brings hope for long‑term change.

Its work focuses on funding groundbreaking ALS research, advocating for equitable access to care and essential supports, and providing direct programs and services that enhance quality of life for people living with ALS and their caregivers. ALS Canada invests in scientific innovation, clinical research networks, and initiatives that deepen understanding of the disease, while also supporting counselling, equipment programs, and community‑based services that address immediate and ongoing needs.

ALS Canada operates nationally, directing resources to communities across provinces and territories throughout Canada. Through partnerships with provincial ALS societies, research institutions, and national collaborators, the organization ensures that support reaches people and families wherever they are in the country while contributing to global advancements in ALS research.

The organization supports individuals living with ALS, caregivers, research institutions, clinicians, academic partners, and community organizations engaged in care, advocacy, and scientific advancement. It collaborates with national and international research networks, government partners, and health system stakeholders to strengthen services and accelerate discovery.

Funding is structured through research grants, national fundraising initiatives, multi‑year scientific investments, and ongoing programs that provide continuous support to individuals and families. By combining long‑term research funding with sustained community‑based services and advocacy, ALS Canada works toward both immediate improvements in care and transformative progress toward ending ALS.